Carisma Therapeutics Inc.

NASDAQ: CARM · Real-Time Price · USD
0.45
-0.05 (-10.41%)
At close: Jun 20, 2025, 3:59 PM

Carisma Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
17.91M 77.61M 24.19M 28.55M
Short-Term Investments
n/a n/a 27.8M n/a
Long-Term Investments
n/a n/a 30K 20K
Other Long-Term Assets
208K 146K 4.11M -84.93M
Receivables
n/a n/a n/a n/a
Inventory
n/a n/a -825K -24.49M
Other Current Assets
5.92M 2.87M 2.6M n/a
Total Current Assets
23.82M 80.47M 54.59M 29.79M
Property-Plant & Equipment
6.42M 8.94M 13.45M 5.66M
Goodwill & Intangibles
n/a n/a -82.48M 13.06M
Total Long-Term Assets
6.63M 9.08M 17.56M 5.66M
Total Assets
30.46M 89.55M 72.15M 35.45M
Account Payables
2.08M 3.93M 1.73M 2.32M
Deferred Revenue
3.73M 1.41M 2.46M n/a
Short-Term Debt
1.74M n/a n/a n/a
Other Current Liabilities
3.63M 4.07M 8.07M n/a
Total Current Liabilities
16.05M 15.91M 19.67M 7.69M
Long-Term Debt
n/a n/a 33.72M n/a
Other Long-Term Liabilities
318K 926K 1.04M n/a
Total Long-Term Liabilities
42.31M 47.11M 81.61M 1.73M
Total Liabilities
58.37M 63.02M 101.28M 9.43M
Total Debt
2.48M 3.12M 40.16M 2.63M
Common Stock
41K 40K 2K 199K
Retained Earnings
-305.58M -245.1M -158.22M -97M
Comprehensive Income
n/a n/a -41K -199K
Shareholders Equity
-27.91M 26.53M -49.26M 11.63M
Total Investments
n/a n/a 27.8M 20K